Main competitors
Add to a list
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
26
24
21
27
19
19
24
20
26
22
22
25
21
15
19
18
17
17
16
Average 21
Weighted average by Cap. 23
Other Pharmaceuticals